SeaBeLife
ID: 17663920SeaBeLife is a drug developer aiming to block cell necrosis founded in 2019 by Morgane Rousselot.
2
Funding Rounds
$3.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Mo***** Ro******* |
|
- | - |
| Cl**** De******* |
|
- |
Funding
Funding series
Funding Series Analysis
The company SeaBeLife has raised a total of $3.65m in funding over 2 rounds.
Key Insights:
- SeaBeLife Seed Round, October 2025: $2.35m
- SeaBeLife September 2023 Seed Funding Round: $1.3m